Clinical Trial Update: Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating 2% IDL Lotion on skin hydration and transepidermal water loss in females with xerosis, completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerosis Cutis

Drugs mentioned

• 2% IDL Lotion

Snippet

Sponsor: Shyla Cantor | Conditions: Xerosis Cutis | Phase 1, Phase 2 | Status: COMPLETED